PDB50 Long-Term Clinical and Economic Benefit Associated with Liraglutide Versus Sitagliptin Therapy When Added to Metformin in the Treatment of Type 2 Diabetes- a Core Diabetes Model Study
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.971
https://www.valueinhealthjournal.com/article/S1098-3015(12)01036-4/fulltext
Title :
PDB50 Long-Term Clinical and Economic Benefit Associated with Liraglutide Versus Sitagliptin Therapy When Added to Metformin in the Treatment of Type 2 Diabetes- a Core Diabetes Model Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01036-4&doi=10.1016/j.jval.2012.03.971
First page :
A179
Section Title :
Diabetes/Endocrine Disorders
Open access? :
No
Section Order :
462